35662286|t|A General Electro-Synthesis Approach to Amaryllidaceae Alkaloids.
35662286|a|Amaryllidaceae alkaloids appeal to organic chemists with their attractive structures and their impressive antitumor and acetylcholinesterase inhibitory properties. We demonstrate a highly versatile access to this family of natural products. A general protocol with high yields in a sustainable electro-organic key transformation on a metal-free anode to spirodienones facilitates functionalization to the alkaloids. The biomimetic syntheses start with the readily available, inexpensive biogenic starting materials methyl gallate, O-methyl tyramine, and vanillin derivatives. Through known dynamic resolutions, this technology provides access to both enantiomeric series of (epi-)martidine, (epi-)crinine, siculine, and galantamine, clinically prescribed for the treatment of Alzheimer's disease.
35662286	66	90	Amaryllidaceae alkaloids	Chemical	MESH:D047151
35662286	186	206	acetylcholinesterase	Gene	43
35662286	400	405	metal	Chemical	MESH:D008670
35662286	420	433	spirodienones	Chemical	-
35662286	471	480	alkaloids	Chemical	MESH:D000470
35662286	581	595	methyl gallate	Chemical	MESH:C052082
35662286	597	614	O-methyl tyramine	Chemical	MESH:C008510
35662286	620	628	vanillin	Chemical	MESH:C100058
35662286	740	755	(epi-)martidine	Chemical	-
35662286	757	770	(epi-)crinine	Chemical	-
35662286	772	780	siculine	Chemical	-
35662286	786	797	galantamine	Chemical	MESH:D005702
35662286	842	861	Alzheimer's disease	Disease	MESH:D000544
35662286	Negative_Correlation	MESH:D047151	43
35662286	Negative_Correlation	MESH:D005702	MESH:D000544

